Interview with Tomas Luke Marcelo G. Agana III, President & CEO, PHAREX…
Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements…
Address: Units 101-102 G/F Building Alpha, P-AyalaLand TechnoHub, Commonwealth Avenue, Diliman, Quezon City,Philippines
Tel: (632) 433-8088
Web: http://www.pharexhealth.com/
PHAREX HealthCorp, a wholly-owned subsidiary of Pascual Laboratories, Inc., was formally established in April 1972 as the exclusive marketing, sales and distribution arm of Pascual Laboratories, Inc. (Pascuallab). As a matter of fact, PHAREX is short for Pharmaceutical Excellence – the very foundation on which the venture is built.
When Pascuallab formally appointed Metro Drug as its exclusive distributor of brands in 1987, PHAREX then secured the marketing of its generic medicines. The move was timely. Soon after, the Generics Act of 1988 was enforced.
Currently, distribution for PHAREX HealthCorp is handled by Zuellig Pharma.
PHAREX HealthCorp has maintained a strong presence in the Philippine generic pharmaceutical industry for over 20 years. Pioneers in the promotion of company or uni-branded medicines, PHAREX has since grown into one of the industry’s most trusted and prescribed brands.
PHAREX offers premium quality, affordable medicines to millions of Filipinos every day.
PHAREX continues to market products owned and manufactured by Pascuallab: this includes 34 products in 22 Therapeutic Categories, including Chronic Care and Wellness.
Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements…
Teodoro Padilla, Executive Director at the Pharmaceutical and Healthcare Association of the Philippines, and Reiner Gloor, Advisor and Honorary Member, discuss the current objectives and goals of the association, how they are…
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant challenge to the innovative medicines industry but also…
“The IMS Health figures show around three to four percent growth in the marketplace,” remarks Raymund Azurin, chief executive of Zuellig Pharma Philippines, “but we are now at a…
Before the introduction of universal healthcare (UHC), most major private hospitals in the Philippines had to rely on imported products. With the MNCs showing only limited interest in small volumes,…
The inclusion of healthcare as a priority on the presidential agenda has led to knock-on consequences that are being felt across the healthcare value chain in the Philippines. Universal…
Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations processes, strategies that the FDA are applying to the major…
Armando Esguerra, President of Chira Pharmaceuticals, Philippines, explains the concept of chirality, why it is relevant and extremely important in the pharmaceutical industry, and what have been the major challenges…
Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and…
Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall…
Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines,…
Margarita Paz, Managing Director of Total Transcript Solutions (TTSI) Philippines, talks about the reason behind switching to the medical transcription business, despite her nursing degree, how this has become a…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
See our Cookie Privacy Policy Here
